NasdaqGM:CDNABiotechs
CareDx (CDNA) Returns To Quarterly Profit Challenging Skepticism Around Its Earnings Story
CareDx (CDNA) has kicked off 2026 with Q1 revenue of US$117.7 million and basic EPS of US$0.05, alongside trailing twelve month revenue of US$412.8 million and a basic EPS loss of US$0.16. Over recent quarters the company has seen revenue move from US$84.7 million in Q1 2025 to US$117.7 million in Q1 2026, while quarterly basic EPS has ranged from a loss of US$0.19 to a profit of US$0.05. This puts the focus on how sustainably CareDx can convert its top line into healthier margins.
See our...